Accor is a hotel operator. Co. offers its guests and partners the expertise of a hotel operator and brand franchisor (HotelServices) and a hotel owner and investor (HotelInvest). Co. divides its activities into three segments: Luxury-upscale, Midscale and Economy. Luxury-upscale makes up 11% of Co.'s portfolio and comprises brands such as Sofitel, Pullman, MGallery, and Grand Mercure; Midscale makes up 43% of its portfolio and comprises the Novotel, Suite Novotel, Mercure and Adagio brands; and Economy makes up 46% the Co.'s portfolio, comprising the brands ibis, ibis Styles, ibis budget and hotelF1. At Dec 31 2013 Co. operated around 3,600 hotels and 460,000 rooms in 92 countries.
Carnival is a leisure travel and cruise company. Co. operates over 100 cruise ships within a portfolio of global, regional and national cruise brands that sell tailored cruise products, services and vacation experiences. Co.'s North America cruise brands include Carnival Cruise Line, Princess Cruises, Holland America Line, and Seabourn. Co. also has a Cruise Support segment that represents its portfolio of port destinations and private islands, which are operated for the benefit of its cruise brands. In addition to its cruise operations, Co. owns Holland America Princess Alaska Tours, the tour company in Alaska and the Canadian Yukon, which complements Co.'s Alaska cruise operations.
InterContinental Hotels Group is a hotel companies. Co.'s hotel brands are InterContinental Hotels & Resorts, Kimpton Hotels & Restaurants, Hualuxe Hotels & Resorts, Hotel Indigo, EVEN Hotels, Crowne Plaza Hotels & Resorts, Holiday Inn, Holiday Inn Express, Staybridge Suites, Holiday Inn Club Vacations, Holiday Inn Resorts, Candlewood Suites, and Avid Hotels. As of Mar 2 2017, Co.'s had total hotels of 5,348 with 4,433 franchised, 907 managed, eight owned and leased hotels, and 1,655 total hotels in the pipeline.
Intesa Sanpaolo is a commercial bank. Co. is engaged in lending and deposit collection operations in Italy and associated financial services, serving Households, Personal, Small Business, Private and Small and Medium Enterprise customers. Co. provides medium-term credit, leasing, factoring and agribusiness (Mediocredito Italiano), consumer credit (Intesa Sanpaolo Personal Finance), management of electronic payments (Setefi), and trust services (Sirefid). Co. has approximately 4,300 branches, including Retail and Business branches, distributed broadly throughout Italy. At Dec 31 2014, Co. had total assets of Euro646.43 billion.
Melia Hotels International is the parent company of a group engaged in the acquisition, management and operation of hotels. Co. operates its hotel network in Germany, Argentina, Brazil, Bulgaria, Cabo Verde, Chile, China, Costa Rica, Croatia, Cuba, Egypt, Spain, United States, France, Greece, Netherlands, Indonesia, Italy, Luxembourg, Malaysia, Mexico, Panama, Peru, Portugal, Puerto Rico, United Kingdom, Dominican Republic, Singapore, Switzerland, Tunisia, Uruguay, Venezuela and Vietnam under the followings brandnames: Paradisus Resorts®, Melia Hotels & Resorts®, TRYP Hoteles® and Sol Hotels & Resorts®.
Moderna is creating a new category of transformative medicines based on messenger RNA, or mRNA. The company's pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.
NH Hotel is engaged in the operation and management of hotels throughout Spain, the Benelux countries, Germany, and South America.
Rubis is a holding company based in France. Co., through its subsidiaries, is engaged in the bulk import, production or distribution process, and storage of petroleum products in Europe, the Caribbean, and Africa. Co. operates bulk liquid storage facilities for petroleum products, chemicals, fertilizers, edible oils and molasses, and foodstuffs, as well as distributes butane, propane, and petroleum products in wholesale and retail. Co.'s customers primarily include hypermarkets and supermarkets; oil companies; chemists; and traders and intermediaries of fuel, oil or gas, manures, and other liquids.
Scandic Hotels Group Ab. Scandic Hotels Group AB is a Sweden-based company engaged, along with its subsidiaries, in the operation of hotels. The Company's main market in which the Group operates in: Sweden, which includes Swedish hotels that are operated under the Scandic brand; Norway, which includes Norwegian hotels that are operated under the Scandic brand, and Other Nordic countries & segments include hotel operation in Belgium, Denmark, Finland, the Netherlands, Poland and Germany, as well as the hotel concept HTL, which is operated by the sub-group HTL Hotels. The Company operates a network of approximately 224 hotels and almost 42,000 hotel rooms in seven countries. Scandic Hotels Group AB is a wholly owned subsidiary of Sunstorm Holding AB.
TUI is engaged in the tourism business, operating in some 180 countries. Co.'s segments include Hotels & Resorts, Cruises and Other Tourism. The Hotels & Resorts segment comprises all Group-owned hotels and hotel companies in TUI Group. The segment comprises majority participations in hotels, joint ventures with local partners, stakes in companies. The Cruises segment consists of Hapag-Lloyd Cruises and the joint venture TUI Cruises. Other Tourism segment comprises central functions such as destination services, IT, aviation control and the French airline Corsair.
Unicredit is a pan-European commercial banking group based in Italy. Co. is engaged in the provision of in-branch and online corporate and investment banking services, providing customers with access to banks in 14 core markets as well as to an another 18 countries worldwide. Co.'s operations are organized along six business lines: Commercial Banking Italy; CEE Division; CIB; Commercial Banking Germany; Commercial Banking Austria; and Asset Gathering. Co.'s European banking network includes Italy, Germany, Austria, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Hungary, Romania, Russia, Slovakia, Slovenia, Serbia and Turkey.
Uniper SE is a Germany-based energy generation and energy trading company. The Company operates through three segments: European Generation, Global Commodities and International Power Generation. The European Generation segment generates power and owns coal, gas, oil and combined gas and steam power plants, hydroelectric power plants, nuclear power stations in Sweden, a biomass plant in France, as well as solar and wind power facilities; the Global Commodities segment bundles the Company's energy trading activities, as well as its gas storage and supply business, and the International Power Generation segment comprises equity investments in energy generation companies in the Russian Federation and Brazil.
Voyageurs Du Monde. Voyageurs du Monde SA is a France-based travel company. It is engaged in the provision of travel-related services, which includes organizing personalized travel itineraries for individual clients; running guided tours and group holidays; providing special interest package holidays; organizing trips for large groups and associations, and providing flight and hotel reservation services in the number of countries in Africa, South America, Asia, the United States and Europe. Voyageurs du Monde SA runs several specialized travel bookshops throughout France and organizes conferences, exhibitions and craft fairs from around the world. In addition, it offers accommodation services in Morocco, Brazil and Egypt. The Company operates through Comptoir des Voyages SA, Original Travel Co Ltd, Villa Nomade SARL, Villa Bahia, Voyageurs d'Egypte, Satyagraha's Guest House and Ke Adventure Travel, among others. The main shareholder of the Company is Avantage SA.
Whitbread is a hospitality company. Co. serves its customers in the U.K. and beyond through its two businesses: Premier Inn and Restaurants; and Costa. Premier Inn is a hotel business, with over 760 hotels and more than 68,000 rooms as of Mar 2 2017. Co.'s hotel are located alongside its own restaurant brands. Co. also have hotels in the Middle East, and Germany, with more hotels in the pipeline. Costa is the coffee shop, with over 2,200 coffee shops in the U.K., over 1,300 stores in 29 international markets and over 6,800 Costa Express self-serve units as of Mar 2 2017.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
La fusion ISP-UBI devrait relancer la consolidation en Italie. L’Etat italien est de plus en plus sous pression pour solutionner le dossier sensible BMPS. Les options ne sont pas évidentes pour UCG et la plupart des opérations pourraient in fine surtout concerner les acteurs Tier 2/3 dans une optique défensive plutôt qu’attractive. Dans ce contexte, ISP devrait durablement bénéficier de son échappée réussie, nous passons à l'Achat sur le titre. - ...
>CA T3 en-dessous des attentes, RevPAR globalement en ligne - Accor a publié un CA T3 20 à 329 M€ (-69% en publié, dont -63.7% en organique), soit 12% en dessous des attentes à 372 M€, dont des effets négatifs de périmètre (-11%, incl. cession des actifs en location de Mövenpick) et de changes (-5%). Par division, chez HotelServices, le CA atteint 224 M€ (-69% en organique), impacté par une chute du RevPAR de 62.8%, légèrement en dessous du consensus à -60.9% (ODDO BH...
>Q3 revenue below expectations, RevPAR generally in line - Accor has reported Q3 2020 revenue of € 329m (-69% as reported, -63.7% organic), i.e. 12% below expectations of € 372m, including negative scope (-11%, including disposal of Mövenpick’s leased assets) and forex (-5%) effects. By division, HotelServices revenue came in at € 224m (-69% organic), impacted by a drop of 62.8% in RevPAR, slightly below the consensus of -60.9% (ODDO BHF -63.3%), and by a very sharp d...
>Reduce recommendation maintained, target price NOK 2.7 vs 3 - We maintain our Reduce recommendation on the stock (target price NOK 2.7 vs 3) and we cut our earnings forecasts post 2020. The gamble on debt rescheduling should pay off with the first maturities now scheduled for September 2022. This was a point on which the market was focused in the short term, however, in the medium term, the magnitude of the rebound remains difficult to validate. At this stage, t...
>Q3 revenues up 46% to € 73.4m (vs € 52.3m est.) - SES-imagotag reported Q3 revenues well ahead of our expectations: € 73.4m, up 46%, compared to our estimate at +2%, with higher leverage in Q4 than in Q3.The rebound was strong in International markets (87% of Q3): +82% to € 63.9m (vs. €44.2m est.). This growth is linked to the catch-up of certain delayed deployments during the first half of the year and, above all, to the strong order intake momentum seen in rec...
>An unexpected deterioration in Q3 with a decline of around 15.5% - On Thursday after trading, Econocom published 9M 2020 revenues of € 1,825m for continuing operations, which came in below our forecast (€ 1,910m) and represented a decline of -12.5% over the first nine months of the year. This indicates an organic decline of around 15.5% for Q3, which is far deeper we forecast (-4.2%) and shows an acceleration vs the previous quarter (-12.5% org. in Q2 2020). Th...
>A challenging Q3, 9M 2020 still in positive terrain - BB Biotech published its Q3 2020 results this morning. The holding company's share price lost 4.3% in € and 3.4% in CHF over the quarter. The portfolio's NAV fell by 10.9% in CHF, 12.1% in € and 8.3% in $, underperforming its benchmark, the Nasdaq Biotechnology Index (NBI), which fell by just -0.8% over the period. The result was a net loss of -CHF 395m (vs -CHF 382m in Q3 2019). Nevertheless, the holding c...
>Un T3 challenging, performance à 9M toujours dans le vert - BB Biotech publie ce matin ses résultats au titre du T3 2020, le titre de la holding a perdu 4.3% en € et 3.4% en CHF sur le trimestre. La NAV du portefeuille a reculé quant à elle de 10.9 % en CHF, de 12.1% en € et de 8.3 % en $ sous-performant son indice de référence le NBI (Nasdaq Biotechnology Index) qui lui n’a reculé que de -0.8 % sur la période. Il en résulte une perte nette de -395 MCHF (vs -382 MCH...
Unfortunately, this report is not available for the investor type or country you selected.Browse all ResearchPool reports
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.